Latest Prescription Drugs news
Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer
posted July 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
posted July 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Frequent Cannabis Use Linked to Epilepsy Severity Monthly Specialist Briefings
Stay Connected
